Guangdong implemented the model of 'Notice on the Registration of Cefadroxil Drug Alliance Regional Group with Quantity Procurement
Not long ago, the Guangdong Provincial Drug Exchange Center issued the "Notice on the Registration of Cefadroxil Drug Alliance Regional Group Volume Procurement", the volume procurement is only for single product volume, the name is Cefadroxil, the dosage forms involved are oral normal release dosage form, oral liquid dosage form, granules, effervescent tablets, slow release controlled release dosage form, etc., basically involving all the dosage forms currently listed.
At present, there are various forms of procurement with volume, and "generalization is obvious", according to the administrative division, there are national-level procurement with volume, provincial-level procurement with volume, municipal-level procurement with volume, and coalition procurement with volume. In addition, there are original drugs, reference preparations, over-evaluated drugs, non-over-evaluated and other dimensions. Now, Guangdong Province has come out with a full dosage form banding model. The frequent pattern of quantity procurement makes enterprises tired to deal with. The industry believes that the future local collection will gradually form a more mature way in favor of the collection of the main body, the main body of the tender, the main body of the use of drugs, and the province as a unit or several provinces as a unit of the regional alliance collection mode, or will become the mainstream mode of collection.
2026-07-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Ali's Q3 FY2022 Revenue of 242.58 Billion
-
The trend of AI pharmacy is obvious, pharmaceutical companies start layout
-
China's National Narcotics Control Commission Issues Important Notice: Beware of These 8 Chemicals Being Diverted for Drug Production
-
Pharma Tariff Risk Pushes Global Drugmakers to Rebuild U.S. Supply Chains
-
Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate
-
U.S. API Dependence Turns Pharmaceutical Ingredients Into a National Security Issue
-
FDA Dye Phase-Out Push Opens a Bigger Window for Natural Color Solutions
-
Lubrizol Announces Elimination of PFAS from Its Peptide Synthesis Process
-
EU Plans Broader Quotas and Tariffs on China, With Chemicals Clearly Named
-
Trump’s Steel, Aluminum and Copper Tariff Changes Pull Chemical Manufacturing Into the Impact Zone
Recommend Reading
-
API Supplier Audits Move to the Center of Pharma Supply Resilience
-
Supplement Recall Puts Nutrition Ingredient Safety Back Under Pressure
-
Sherwin-Williams Opens High-Performance Industrial Coatings Facility in Saskatchewan
-
U.S. Chemical Tariff Deadline Nears as the Industry Faces Cost Repricing and Supply-Chain Adjustment
-
EU Finalizes Anti-Dumping Duties on Chinese Adipic Acid as Chemical Trade Enters a Rule-Intensive Phase
-
Supply Shortage Leads to Increase in Activated Carbon Prices
-
Butadiene Rubber Market Prices Drop Sharply
-
Narrow Fluctuations in Phosphate Prices in China (9.5-9.11)
-
Cost-side support weakens, PTA price center of gravity continues to shift downward
-
Syngenta Bee Pesticide Protest Shows the Pressure Building Around Crop Protection Giants